来自专业的译者、企业、网页和免费的翻译库。
trastuzumab
trastuzumab
最后更新: 2012-04-11
使用频率: 2
质量:
substanţa activă este trastuzumab.
the active substance is trastuzumab.
最后更新: 2017-04-26
使用频率: 3
质量:
docetaxel în asociere cu trastuzumab
docetaxel in combination with trastuzumab
最后更新: 2017-04-26
使用频率: 1
质量:
docetaxel kabi în asociere cu trastuzumab
docetaxel kabi in combination with trastuzumab
最后更新: 2017-04-26
使用频率: 1
质量:
substanţa activă este trastuzumab emtansine.
the active substance is trastuzumab emtansine.
最后更新: 2017-04-26
使用频率: 1
质量:
herceptin 600 mg soluţie injectabilă trastuzumab
herceptin 600 mg solution for injection trastuzumab
最后更新: 2017-04-26
使用频率: 1
质量:
se va întrerupe administrarea trastuzumab emtansine.
discontinue trastuzumab emtansine.
最后更新: 2017-04-26
使用频率: 1
质量:
0,0030 (vs perjeta+ trastuzumab+ docetaxel)
0.0030 (vs perjeta+ trastuzumab+ docetaxel)
最后更新: 2017-04-26
使用频率: 1
质量:
efectul medicamentelor antineoplazice asupra farmacocineticii trastuzumab
effect of antineoplastic agents on trastuzumab pharmacokinetics
最后更新: 2017-04-26
使用频率: 1
质量:
un flacon conţine trastuzumab 600 mg/5 ml.
one vial contains 600 mg/5 ml trastuzumab.
最后更新: 2017-04-26
使用频率: 1
质量:
docetaxel 100 mg/m2 în asociere cu trastuzumab:
docetaxel 100 mg/m² in combination with trastuzumab:
最后更新: 2017-04-26
使用频率: 1
质量:
după reconstituire, 1 ml concentrat conţine trastuzumab 21 mg.
after reconstitution 1 ml concentrate contains 21 mg of trastuzumab
最后更新: 2017-04-26
使用频率: 3
质量:
92 pacienţi trataţi cu docetaxel în asociere cu trastuzumab.
92 patients treated with docetaxel in combination with trastuzumab.
最后更新: 2017-04-26
使用频率: 1
质量:
92 pacienţi care au primit docetaxel în asociere cu trastuzumab.
92 patients treated with docetaxel in combination with trastuzumab.
最后更新: 2017-04-26
使用频率: 1
质量:
herceptin 600 mg soluţie injectabilă în sistem de administrare trastuzumab
herceptin 600 mg solution for injection in administration system trastuzumab
最后更新: 2017-04-26
使用频率: 1
质量:
nu există antidot cunoscut pentru supradozajul cu trastuzumab emtansine.
there is no known antidote for trastuzumab emtansine overdose.
最后更新: 2017-04-26
使用频率: 1
质量:
herceptin 150 mg pulbere pentru concentrat pentru soluţie perfuzabilă trastuzumab
herceptin 150 mg powder for concentrate for solution for infusion trastuzumab
最后更新: 2017-04-26
使用频率: 5
质量:
dm1, componenta citotoxică a trastuzumab emtansine, se leagă de tubulină.
dm1, the cytotoxic component of trastuzumab emtansine, binds to tubulin.
最后更新: 2017-04-26
使用频率: 1
质量:
pentru mai multe detalii, vezi rezumatul caracteristicilor produsului pentru trastuzumab.
for more details see summary of product characteristics of trastuzumab.
最后更新: 2017-04-26
使用频率: 3
质量:
nu au fost raportate reacţii adverse suplimentare privind asocierea lapatinibului cu trastuzumab.
no additional adverse reactions were reported to be associated with lapatinib in combination with trastuzumab.
最后更新: 2017-04-26
使用频率: 1
质量: